Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship (Q38073603)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 January 2013

Language	Label	Description	Also known as
English	Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship	scientific article published on 11 January 2013

Statements

scholarly article

1 reference

Europe PubMed Central

28 August 2017

1 reference

Europe PubMed Central

Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship (English)

1 reference

Europe PubMed Central

28 August 2017

Alzheimer's disease

0 references

type 2 diabetes

0 references

0 references

author name string

Nicholas T Vagelatos

1

1 reference

Europe PubMed Central

28 August 2017

Guy D Eslick

2

1 reference

Europe PubMed Central

28 August 2017

publication date

11 January 2013

1 reference

Europe PubMed Central

28 August 2017

Epidemiologic Reviews

1 reference

Europe PubMed Central

28 August 2017

35

1 reference

Europe PubMed Central

28 August 2017

152-160

1 reference

Europe PubMed Central

28 August 2017

National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Epidemiology of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Global estimates of the prevalence of diabetes for 2010 and 2030

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Forecasting the global burden of Alzheimer’s disease

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Cost of Alzheimer's disease and related dementia in managed-medicare.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Health care expenditures for people with diabetes mellitus, 1992.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Economic costs of diabetes in the US in 2002.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

2012 Alzheimer's disease facts and figures

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Aggregation of vascular risk factors and risk of incident Alzheimer disease

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Developmental and vascular risk factors for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Glucose tolerance status and risk of dementia in the community: the Hisayama study

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Diabetes is related to cerebral infarction but not to AD pathology in older persons.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Prevalence of dementia disorders in the oldest-old: an autopsy study.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Human cerebral neuropathology of Type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Different patterns of cerebral injury in dementia with or without diabetes

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Mixed brain pathologies account for most dementia cases in community-dwelling older persons.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

The neuropathology of probable Alzheimer disease and mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

The influence of smoking on the risk of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

An 18-year follow-up of overweight and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Risk of Alzheimer's disease in relation to diabetes: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Exposure measurement in cohort studies: the challenges of prospective data collection

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

AD lesions and infarcts in demented and non-demented Japanese-American men.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Alcohol and tobacco consumption as risk factors of dementia: a review of epidemiological studies

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Amyloid angiopathy-related vascular cognitive impairment.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Apolipoprotein E allele-dependent antioxidant activity in brains with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Relationship between oxidative stress and apoE phenotype in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

How does diabetes accelerate Alzheimer disease pathology?

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Vascular dementia: distinguishing characteristics, treatment, and prevention

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Vascular risks and incident dementia: results from a cohort study of the very old.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Mid-life and late-life vascular risk factors and dementia in Korean men and women.

1 reference

https://api.crossref.org/works/10.1093%2FEPIREV%2FMXS012

21 January 2018

Identifiers

10.1093/EPIREV/MXS012

1 reference

Europe PubMed Central

28 August 2017

1 reference

Europe PubMed Central

28 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38073603&oldid=1739240187"